Vertex And NHS England To Do 'More Talking’ This Week On Reimbursing Orkambi

 
• By Vibha Sharma

Vertex Pharmaceuticals and NHS England are due to meet this week to see whether they can resolve their pricing deadlock over the cystic fibrosis drug Orkambi. Meanwhile, UK ministers are urging the company to bring these negotiations to an urgent resolution.

Cystic Fibrosis
UK Ministers Request Urgent Resolution To Orkambi's Pricing Deadlock • Source: Shutterstock

More from Market Access

More from Pink Sheet